The prevalence of diabetes mellitus in Kazakhstan: a systematic review and meta-analysis
Keywords:
Diabetes Mellitus, prevalence, systematic review, meta-analysis, KazakhstanAbstract
Background and aim: Accurately determining the prevalence of diabetes mellitus (DM) in Kazakhstan has posed challenges due to discrepancies in reported figures. This study seeks to elucidate the annual trends in diabetes mellitus prevalence in Kazakhstan based on the systematic review of the published literature.
Methods: A comprehensive search was conducted in five electronic literature databases: PubMed, Web of Science, ScienceDirect, Academic Search Complete, and Google Scholar. After including initial studies, we conducted a reference search to obtain additional information.
Results: Five articles met the criteria for inclusion in the systematic review. After reference search of the included articles, we added the MedInfo registry into the meta-analysis and eliminated duplicate data from the pooled prevalence estimation. Constant upward trend was observed in DM prevalence. The pooled mean DM prevalence in 2004 was 832.24 per 100,000 individuals, with significant heterogeneity observed across studies. For 2021, the pooled mean prevalence was 3743.92 per 100,000 individuals. Meta-regression revealed a significant association between DM prevalence and the male population. Sensitivity analysis identified data from 2021 as influential, contributing to publication bias.
Conclusions: The study highlights an increasing trend in DM prevalence in Kazakhstan from 2004 to 2021. Gender-specific interventions may be warranted based on the association between DM prevalence and male populations. These findings underscore the need for enhanced methodologies in epidemiological studies to inform targeted public health strategies and healthcare policies addressing DM in Kazakhstan.
References
Institute for Health Metrics and Evaluation. Global diabetes cases to soar from 529 million to 1.3 billion by 2050. 2023. Available from: https://www.healthdata.org/news-events/newsroom/news-releases/global-diabetes-cases-soar-529-million-13-billion-2050
Cho NH, Shaw JE, Karuranga S, et al. IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81. doi: 10.1016/j.diabres.2018.02.023
Herman WH. The global burden of diabetes: An overview. Diabetes Mellitus in Developing Countries and Underserved Communities. 2016 Jan 1;1–5.
Bommer C, Sagalova V, Heesemann E, et al. Global economic burden of diabetes in adults: projections from 2015 to 2030. Diabetes Care. 2018;41(5):963–70. doi: 10.2337/dc17-1962
Centers for Disease Control and Prevention. CDC. 2022. Diabetes Risk Factors. Available from: https://www.cdc.gov/diabetes/basics/risk-factors.html
Adambekov S, Kaiyrlykyzy A, Igissinov N, Linkov F. Health challenges in Kazakhstan and central Asia. J Epidemiol Community Health. 2016;70(1):104–8. doi: 10.1136/jech-2015-206251
Kabdesov K. Urbanization Trends and Processes in Kazakhstan. Eurasian Journal of Economic and Business Studies. 2020;55(1):37–49. doi: 10.47703/ejebs.v1i55.11
Turekulova D, Beisengaliyev B, Turekulova A, Saimagambetova G. Improvement of indicators of socio-economic development of the regions of Kazakhstan. In: E3S Web of Conferences. EDP Sciences; 2023. p. 08041. doi: 10.1051/e3sconf/202340208041
Sagidolda N, Rakhmetova R, Musulmankulova A, Abenova K, Kazykeshova A. Socio-economic sustainable development of the regions of Kazakhstan: Research of demographic potential. Journal of Environmental Management and Tourism. 2019;10(5):1124–34. doi: 10.14505//jemt.10.5(37).19
Fursov RA, Ospanov OB, Fursov AB. Obesity as an Actual Problem: Spatial Research in Kazakhstan (2011-2016). Indian J Public Health Res Dev. 2018;9(7). doi: 10.5958/0976-5506.2018.00603.4
Fursov R, Ospanov O, Fursov A. Prevalence of obesity in Kazakhstan. Australasian Medical Journal (Online). 2017;10(11):916–20. doi: 10.21767/AMJ.2017.3169
Adilovna ZM, Pazylbekovna KG, Smailkhanovna AN. Prevalence and correlates of insufficient physical activity among diabetic patients in Almaty, Kazakhstan. Экология человека. 2021;(10):44–50. doi: 10.33396/1728-0869-2021-10-44-50
Huang D, Refaat M, Mohammedi K, Jayyousi A, Al Suwaidi J, Abi Khalil C. Macrovascular complications in patients with diabetes and prediabetes. Biomed Res Int. 2017;2017(1):1-9. doi: 10.1155/2017/7839101
Tazhiyeva AE, Reznik VL, Ivanov S V, Grjibovski AM. Prevalence of complications of type 2 diabetes mellitus and related diseases in 2012-2016 in Almaty, Kazakhstan. Hum Ecol. 2017;10:57–64. doi: 10.33396/1728-0869-2017-10-57-64
National Institute for Health and Care Research. NIHR. 2024. PROSPERO. International prospective register of systematic reviews. Available from: https://www.crd.york.ac.uk/prospero/
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj. 2021;372. doi: 10.1136/bmj.n71
CASP. CASP Qualitative Research Checklist, 2017. Critical Appraisal Skills Programme, UK. 2017. Available from: https://casp-uk.net/casp-tools-checklists/
Posit team. Posit Software, PBC. 2023. RStudio: Integrated Development Environment for R. Available from: http://www.posit.co/
Galiyeva D, Gusmanov A, Sakko Y, et al. Epidemiology of type 1 and type 2 diabetes mellitus in Kazakhstan: data from unified National Electronic Health System 2014–2019. BMC Endocr Disord. 2022;22(1):275. doi: 10.1186/s12902-022-01200-6
Danyarova L, Kuanyshbekova R, Svyatova G, Berezina G, Sultanova B. Gestational diabetes mellitus as a predictor of type 2 diabetes mellitus: cardiovascular risk factors and biological markers in Kazakh women. J Hypertens. 2023;41(Suppl 1):e490. doi: 10.1097/01.hjh.0000917924.38773.51
Supiyev A, Kossumov A, Kassenova A, et al. Diabetes prevalence, awareness and treatment and their correlates in older persons in urban and rural population in the Astana region, Kazakhstan. Diabetes Res Clin Pract. 2016;112:6–12. doi: 10.1016/j.diabres.2015.11.011
Orazumbekova B, Issanov A, Atageldiyeva K, et al. Prevalence of impaired fasting glucose and type 2 diabetes in Kazakhstan: findings from large study. Front Public Health. 2022;10:810153. doi: 10.3389/fpubh.2022.810153
Mukasheva A, Akanov Z, Yedilkhan D. Research of the Regression Analysis Methods for Predicting the Growth of Patients with Diabetes Mellitus. In: 2021 IEEE International Conference on Smart Information Systems and Technologies (SIST). IEEE; 2021. p. 1–7. doi: 10.1109/SIST50301.2021.9465975
Sikhayeva N, Talzhanov Y, Iskakova A, et al. Type 2 diabetes mellitus: distribution of genetic markers in Kazakh population. Clin Interv Aging. 2018;377–88. doi: 10.2147/CIA.S156044
Mukasheva A, Saparkhojayev N, Akanov Z, Algazieva A. The prevalence of diabetes in the Republic of Kazakhstan based on regression analysis methods. International Journal of Health and Medical Sciences. 2019;5(1):8–16. doi: 10.20469/ijhms.5.30002-1
Beissova A, Kamkhen V, Turbekova M, Malgazhdarov M, Koshkimbayeva S, Kozhabek L. Epidemiological Features of Diabetes in Kazakhstan in 2018-2021 (Population Study). Med J Islam Repub Iran. 2023;37.35:1-7. doi: 10.47176/mjiri.37.35
Mukasheva A, Yedilkhan D, Mustafina B. Assessment of Diabetes Mellitus Epidemiological Situation in Kazakhstan: A Statistical Approach. In: 2022 International Conference on Smart Information Systems and Technologies (SIST). IEEE; 2022. p. 1–6. doi: 10.1109/SIST54437.2022.9945798
Alimbayev A, Zhakhina G, Gusmanov A, et al. Predicting 1-year mortality of patients with diabetes mellitus in Kazakhstan based on administrative health data using machine learning. Sci Rep. 2023;13(1):8412. doi: 10.1038/s41598-023-35551-4
MedInfo. Diabetes Mellutis Prevalence in the Republic of Kazakhstan. 2018. Available from: medinfo.kz
Mota M, Stefan AG. Covid-19 and Diabetes–A Bidirectional Relationship? Rom J Diabetes Nutr Metab Dis. 2020;27(2):77–9. doi: 10.46389/rjd-2020-1013
Lima-Martínez MM, Boada CC, Madera-Silva MD, Marín W, Contreras M. COVID-19 and diabetes: A bidirectional relationship. Clin Investig Arterioscler. 2021;33(3):151–157. doi: 10.1016/j.artere.2021.04.004
Hussain S, Baxi H, Jamali MC, Nisar N, Hussain MS. Burden of diabetes mellitus and its impact on COVID-19 patients: a meta-analysis of real-world evidence. Diabetes Metab Syndr. 2020;14(6):1595–1602. doi: 10.1016/j.dsx.2020.08.014
Cariou B, Wargny M, Boureau AS, et al. Impact of diabetes on COVID-19 prognosis beyond comorbidity burden: the CORONADO initiative. Diabetologia. 2022;65(9):1436–49. doi: 10.1007/s00125-022-05734-1
Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311–21. doi: 10.1016/S2213-8587(22)00044-4
Sharma P, Behl T, Sharma N, et al. COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality. Biomed Pharmacother. 2022;151:1-10. doi: 10.1016/j.biopha.2022.113089
Gusmanov A, Zhakhina G, Yerdessov S, et al. Review of the research databases on population-based Registries of Unified electronic Healthcare system of Kazakhstan (UNEHS): Possibilities and limitations for epidemiological research and Real-World Evidence. Int J Med Inform. 2023 Feb 1;170:104950. doi: 10.1016/j.ijmedinf.2022.104950
Ciarambino T, Crispino P, Leto G, Mastrolorenzo E, Para O, Giordano M. Influence of gender in diabetes mellitus and its complication. Int J Mol Sci. 2022;23(16):8850. doi: 10.3390/ijms23168850
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Assem Kazbekova, Zhanay Akanov , Dana Abseitova, Zhanar Buribaeva , Zhanar Rakhymbayeva , Sanjay Kalra, Manzura Baimukhanova
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
